NKI-AVL, Department of Thoracic-Oncology

Amsterdam 1066 CX

0 studies enrolling now · 2 studies all time

What they study most

ALK-positive Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer

Studies at this site

• A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges — Completed
• A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification — Stopped early